|
Market Cap (2-Jul) $147,983,008 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (19-Jun) 1,473,254 (0.38%) (338th) |
|
52w High $0.66 |
52w Low $0.165 |
P/E - |
EPS -0.05 |
A news article has been posted about Paradigm Biopharmaceuticals on the AFR. The article was published around , on 13 March 2022 at 4:05pm.
Any Morgans clients who moved quickly on the retail broker’s advice to dump Paradigm Biopharmaceuticals must be ruing their timing.
Read ArticlePAR was $1.20 at the close of trade on 11 March 2022
| Recent Articles about ASX:PAR | |
|---|---|
| 27-Jun | ASX RELEASE 26 June 2025 Paradigm Acquires Proteobioactives ...
company-announcements.afr.com |
| 27-Jun | ASX RELEASE 3 June 2025 Site Activation and First Patient ...
company-announcements.afr.com |
| 17-Jun | ASX RELEASE 29 May 2025 Results of General Meeting Paradigm ...
company-announcements.afr.com |
| 17-Jun | Notice of General Meeting
company-announcements.afr.com |
| 30-Mar | S&P Dow Jones Indices Announces March 2025 Quarterly ...
company-announcements.afr.com |
| 18-Mar | Paradigm to present at NWR Virtual Healthcare Conference
company-announcements.afr.com |
| 14-Mar | Appendix 2A - Application for quotation of securities
company-announcements.afr.com |
| 28-Feb | Paradigm Biopharmaceuticals Limited Appendix 4D Half-year report ...
company-announcements.afr.com |
| 25-Feb | ethics approval in australia for para_oa_012 phase 3 trial
company-announcements.afr.com |
| 13-Feb | Appendix 2A - Application for quotation of securities
company-announcements.afr.com |
| Tracked |
Find all articles about Paradigm Biopharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 